Peter J. Carman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peter J. Carman has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Roberto Dominguez
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
11 shared publications - Kyle R. Barrie
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
4 shared publications - Malgorzata Boczkowska
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
3 shared publications - Andres E. Leschziner
Department of Biochemistry and Biophysics, Weill Cornell Medicine, New York, NY 10065 USA
2 shared publications - Erika L. F. Holzbaur
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2 shared publications - Grzegorz Rebowski
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
2 shared publications
Latest Publications
- Open Access
- 20 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (12) , eaeb4543
Mechanisms of CARMIL dimerization, autoinhibition, and capping protein binding
Capping protein (CP) regulates actin-based motility by blocking monomer exchange at the filament barbed end. Several proteins, including CARMIL, bind CP and allosterically weaken its affinity for the barbed end. CARMIL comprises pleckstrin homology (PH), leucine-rich repeat (LRR), helical dimerization (HD), CP-binding region (CBR), and proline-rich (PR) domains, but their roles in CP regulation remain unclear. We show that CARMIL1 is partially autoinhibited, with CBR (CARMIL1 961–1046 ) displaying greater uncapping activity than CARMIL1 1–1046 . A structure of CP-bound CARMIL1 1–1046 reveals a dimeric assembly, with PH-LRR on a plane flanked by HD and CBR-bound CP. A motif connecting HD to CBR-CP, the “antenna,” binds at the dimer LRR-LRR interface. An antenna mutant disrupting this interaction partially relieves autoinhibition in vitro. In CARMIL1 knockout cells, expression of the antenna mutant increases cell area, while deleting the myosin-I–binding PR domain induces membrane spikes. The results inform mechanisms of CARMIL dimerization, autoinhibition, and coordination of CP and myosin-I activities in cells.
- 20 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (12) , eaeb4543
Open AccessMechanisms of CARMIL dimerization, autoinhibition, and capping protein binding
Capping protein (CP) regulates actin-based motility by blocking monomer exchange at the filament barbed end. Several proteins, including CARMIL, bind CP and allosterically weaken its affinity for the barbed end. CARMIL comprises pleckstrin homology (PH), leucine-rich repeat (LRR), helical dimerization (HD), CP-binding region (CBR), and proline-rich (PR) domains, but their roles in CP regulation remain unclear. We show that CARMIL1 is partially autoinhibited, with CBR (CARMIL1 961–1046 ) displaying greater uncapping activity than CARMIL1 1–1046 . A structure of CP-bound CARMIL1 1–1046 reveals a dimeric assembly, with PH-LRR on a plane flanked by HD and CBR-bound CP. A motif connecting HD to CBR-CP, the “antenna,” binds at the dimer LRR-LRR interface. An antenna mutant disrupting this interaction partially relieves autoinhibition in vitro. In CARMIL1 knockout cells, expression of the antenna mutant increases cell area, while deleting the myosin-I–binding PR domain induces membrane spikes. The results inform mechanisms of CARMIL dimerization, autoinhibition, and coordination of CP and myosin-I activities in cells.
- Open Access
- 31 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (22) , eadn6615
Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy
Visceral myopathy is a life-threatening disease characterized by muscle weakness in the bowel, bladder, and uterus. Mutations in smooth muscle γ-actin (ACTG2) are the most common cause of the disease, but the mechanisms by which the mutations alter muscle function are unknown. Here, we examined four prevalent ACTG2 mutations (R40C, R148C, R178C, and R257C) that cause different disease severity and are spread throughout the actin fold. R178C displayed premature degradation, R148C disrupted interactions with actin-binding proteins, R40C inhibited polymerization, and R257C destabilized filaments. Because these mutations are heterozygous, we also analyzed 50/50 mixtures with wild-type (WT) ACTG2. The WT/R40C mixture impaired filament nucleation by leiomodin 1, and WT/R257C produced filaments that were easily fragmented by smooth muscle myosin. Smooth muscle tropomyosin isoform Tpm1.4 partially rescued the defects of R40C and R257C. Cryo–electron microscopy structures of filaments formed by R40C and R257C revealed disrupted intersubunit contacts. The biochemical and structural properties of the mutants correlate with their genotype-specific disease severity.
- 31 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (22) , eadn6615
Open AccessMolecular mechanisms linking missense ACTG2 mutations to visceral myopathy
Visceral myopathy is a life-threatening disease characterized by muscle weakness in the bowel, bladder, and uterus. Mutations in smooth muscle γ-actin (ACTG2) are the most common cause of the disease, but the mechanisms by which the mutations alter muscle function are unknown. Here, we examined four prevalent ACTG2 mutations (R40C, R148C, R178C, and R257C) that cause different disease severity and are spread throughout the actin fold. R178C displayed premature degradation, R148C disrupted interactions with actin-binding proteins, R40C inhibited polymerization, and R257C destabilized filaments. Because these mutations are heterozygous, we also analyzed 50/50 mixtures with wild-type (WT) ACTG2. The WT/R40C mixture impaired filament nucleation by leiomodin 1, and WT/R257C produced filaments that were easily fragmented by smooth muscle myosin. Smooth muscle tropomyosin isoform Tpm1.4 partially rescued the defects of R40C and R257C. Cryo–electron microscopy structures of filaments formed by R40C and R257C revealed disrupted intersubunit contacts. The biochemical and structural properties of the mutants correlate with their genotype-specific disease severity.
- Open Access
The LexA-RecA* structure reveals a lock-and-key mechanism for SOS activation
The bacterial SOS response plays a key role in adaptation to DNA damage, including that caused by antibiotics. SOS induction begins when activated RecA*, an oligomeric nucleoprotein filament formed on single-stranded DNA, binds to and stimulates autoproteolysis of the repressor LexA. Here, we present the structure of the complete SOS signal complex, constituting full-length LexA bound to RecA*. We uncover an extensive interface unexpectedly including the LexA DNA-binding domain, providing a new molecular rationale for ordered SOS response gene induction. Furthermore, we find that the interface involves three RecA monomers, with a single residue in the central monomer acting as a molecular key, inserting into an allosteric binding pocket to induce LexA cleavage. Given the pro-mutagenic nature of SOS activation, our structural and mechanistic insights provide a foundation for developing new therapeutics to slow the evolution of antibiotic resistance.
Open AccessThe LexA-RecA* structure reveals a lock-and-key mechanism for SOS activation
The bacterial SOS response plays a key role in adaptation to DNA damage, including that caused by antibiotics. SOS induction begins when activated RecA*, an oligomeric nucleoprotein filament formed on single-stranded DNA, binds to and stimulates autoproteolysis of the repressor LexA. Here, we present the structure of the complete SOS signal complex, constituting full-length LexA bound to RecA*. We uncover an extensive interface unexpectedly including the LexA DNA-binding domain, providing a new molecular rationale for ordered SOS response gene induction. Furthermore, we find that the interface involves three RecA monomers, with a single residue in the central monomer acting as a molecular key, inserting into an allosteric binding pocket to induce LexA cleavage. Given the pro-mutagenic nature of SOS activation, our structural and mechanistic insights provide a foundation for developing new therapeutics to slow the evolution of antibiotic resistance.
- 23 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 380 (6651) , 1287-1292
Structures of the free and capped ends of the actin filament
The barbed and pointed ends of the actin filament (F-actin) are the sites of growth and shrinkage and the targets of capping proteins that block subunit exchange, including CapZ at the barbed end and tropomodulin at the pointed end. We describe cryo-electron microscopy structures of the free and capped ends of F-actin. Terminal subunits at the free barbed end adopt a “flat” F-actin conformation. CapZ binds with minor changes to the barbed end but with major changes to itself. By contrast, subunits at the free pointed end adopt a “twisted” monomeric actin (G-actin) conformation. Tropomodulin binding forces the second subunit into an F-actin conformation. The structures reveal how the ends differ from the middle in F-actin and how these differences control subunit addition, dissociation, capping, and interactions with end-binding proteins.
- 23 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 380 (6651) , 1287-1292
Structures of the free and capped ends of the actin filament
The barbed and pointed ends of the actin filament (F-actin) are the sites of growth and shrinkage and the targets of capping proteins that block subunit exchange, including CapZ at the barbed end and tropomodulin at the pointed end. We describe cryo-electron microscopy structures of the free and capped ends of F-actin. Terminal subunits at the free barbed end adopt a “flat” F-actin conformation. CapZ binds with minor changes to the barbed end but with major changes to itself. By contrast, subunits at the free pointed end adopt a “twisted” monomeric actin (G-actin) conformation. Tropomodulin binding forces the second subunit into an F-actin conformation. The structures reveal how the ends differ from the middle in F-actin and how these differences control subunit addition, dissociation, capping, and interactions with end-binding proteins.
- Open Access
- 5 October 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (41)
A solution to the long-standing problem of actin expression and purification
Actin is the most abundant protein in the cytoplasm of eukaryotic cells and interacts with hundreds of proteins to perform essential functions, including cell motility and cytokinesis. Numerous diseases are caused by mutations in actin, but studying the biochemistry of actin mutants is difficult without a reliable method to obtain recombinant actin. Moreover, biochemical studies have typically used tissue-purified α-actin, whereas humans express six isoforms that are nearly identical but perform specialized functions and are difficult to obtain in isolation from natural sources. Here, we describe a solution to the problem of actin expression and purification. We obtain high yields of actin isoforms in human Expi293F cells. Experiments along the multistep purification protocol demonstrate the removal of endogenous actin and the functional integrity of recombinant actin isoforms. Proteomics analysis of endogenous vs. recombinant actin isoforms confirms the presence of native posttranslational modifications, including N-terminal acetylation achieved after affinity-tag removal using the actin-specific enzyme Naa80. The method described facilitates studies of actin under fully native conditions to determine differences among isoforms and the effects of disease-causing mutations that occur in all six isoforms.
- 5 October 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (41)
Open AccessA solution to the long-standing problem of actin expression and purification
Actin is the most abundant protein in the cytoplasm of eukaryotic cells and interacts with hundreds of proteins to perform essential functions, including cell motility and cytokinesis. Numerous diseases are caused by mutations in actin, but studying the biochemistry of actin mutants is difficult without a reliable method to obtain recombinant actin. Moreover, biochemical studies have typically used tissue-purified α-actin, whereas humans express six isoforms that are nearly identical but perform specialized functions and are difficult to obtain in isolation from natural sources. Here, we describe a solution to the problem of actin expression and purification. We obtain high yields of actin isoforms in human Expi293F cells. Experiments along the multistep purification protocol demonstrate the removal of endogenous actin and the functional integrity of recombinant actin isoforms. Proteomics analysis of endogenous vs. recombinant actin isoforms confirms the presence of native posttranslational modifications, including N-terminal acetylation achieved after affinity-tag removal using the actin-specific enzyme Naa80. The method described facilitates studies of actin under fully native conditions to determine differences among isoforms and the effects of disease-causing mutations that occur in all six isoforms.
- Open Access
- 1 September 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (4) , 101154
Novel human cell expression method reveals the role and prevalence of posttranslational modification in nonmuscle tropomyosins
- 1 September 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (4) , 101154
Open AccessNovel human cell expression method reveals the role and prevalence of posttranslational modification in nonmuscle tropomyosins
- Open Access
- 20 May 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 220 (7)
Sequential dynein effectors regulate axonal autophagosome motility in a maturation-dependent pathway
Autophagy is a degradative pathway required to maintain homeostasis. Neuronal autophagosomes form constitutively at the axon terminal and mature via lysosomal fusion during dynein-mediated transport to the soma. How the dynein–autophagosome interaction is regulated is unknown. Here, we identify multiple dynein effectors on autophagosomes as they transit along the axons of primary neurons. In the distal axon, JIP1 initiates autophagosomal transport. Autophagosomes in the mid-axon require HAP1 and Huntingtin. We find that HAP1 is a dynein activator, binding the dynein–dynactin complex via canonical and noncanonical interactions. JIP3 is on most axonal autophagosomes, but specifically regulates the transport of mature autolysosomes. Inhibiting autophagosomal transport disrupts maturation, and inhibiting autophagosomal maturation perturbs the association and function of dynein effectors; thus, maturation and transport are tightly linked. These results reveal a novel maturation-based dynein effector handoff on neuronal autophagosomes that is key to motility, cargo degradation, and the maintenance of axonal health.
- 20 May 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 220 (7)
Open AccessSequential dynein effectors regulate axonal autophagosome motility in a maturation-dependent pathway
Autophagy is a degradative pathway required to maintain homeostasis. Neuronal autophagosomes form constitutively at the axon terminal and mature via lysosomal fusion during dynein-mediated transport to the soma. How the dynein–autophagosome interaction is regulated is unknown. Here, we identify multiple dynein effectors on autophagosomes as they transit along the axons of primary neurons. In the distal axon, JIP1 initiates autophagosomal transport. Autophagosomes in the mid-axon require HAP1 and Huntingtin. We find that HAP1 is a dynein activator, binding the dynein–dynactin complex via canonical and noncanonical interactions. JIP3 is on most axonal autophagosomes, but specifically regulates the transport of mature autolysosomes. Inhibiting autophagosomal transport disrupts maturation, and inhibiting autophagosomal maturation perturbs the association and function of dynein effectors; thus, maturation and transport are tightly linked. These results reveal a novel maturation-based dynein effector handoff on neuronal autophagosomes that is key to motility, cargo degradation, and the maintenance of axonal health.
- Open Access
Novel human cell expression method reveals the role and prevalence of posttranslational modification in non-muscle tropomyosins
Biochemical studies require large protein quantities, which are typically obtained using bacterial expression. However, the folding machinery of bacteria is inadequate for many mammalian proteins, which additionally undergo posttranslational modifications (PTMs) that bacteria, yeast, or insect cells cannot perform. Many proteins also require native N- and C-termini and cannot tolerate extra tag amino acids for function. Tropomyosin, a coiled coil that decorates most actin filaments in cells, requires both native N- and C-termini and PTMs, specifically N-terminal acetylation, to polymerize along actin filaments. Here, we describe a new method that combines native protein expression in human cells with an intein-based purification tag that can be precisely removed after purification. Using this method, we expressed several non-muscle tropomyosin isoforms. Mammalian cell-expressed tropomyosins are functionally different from their E. coli -expressed counterparts, display multiple types of PTMs, and can form heterodimers. This method can be extended to other proteins, as demonstrated here for α-synuclein.
Open AccessNovel human cell expression method reveals the role and prevalence of posttranslational modification in non-muscle tropomyosins
Biochemical studies require large protein quantities, which are typically obtained using bacterial expression. However, the folding machinery of bacteria is inadequate for many mammalian proteins, which additionally undergo posttranslational modifications (PTMs) that bacteria, yeast, or insect cells cannot perform. Many proteins also require native N- and C-termini and cannot tolerate extra tag amino acids for function. Tropomyosin, a coiled coil that decorates most actin filaments in cells, requires both native N- and C-termini and PTMs, specifically N-terminal acetylation, to polymerize along actin filaments. Here, we describe a new method that combines native protein expression in human cells with an intein-based purification tag that can be precisely removed after purification. Using this method, we expressed several non-muscle tropomyosin isoforms. Mammalian cell-expressed tropomyosins are functionally different from their E. coli -expressed counterparts, display multiple types of PTMs, and can form heterodimers. This method can be extended to other proteins, as demonstrated here for α-synuclein.
- 7 December 2020
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 28 (1) , 71-80
Structural insights into assembly and function of the RSC chromatin remodeling complex
SWI/SNF chromatin remodelers modify the position and spacing of nucleosomes and, in humans, are linked to cancer. To provide insights into the assembly and regulation of this protein family, we focused on a subcomplex of the Saccharomyces cerevisiae RSC comprising its ATPase (Sth1), the essential actin-related proteins (ARPs) Arp7 and Arp9 and the ARP-binding protein Rtt102. Cryo-EM and biochemical analyses of this subcomplex shows that ARP binding induces a helical conformation in the helicase-SANT–associated (HSA) domain of Sth1. Surprisingly, the ARP module is rotated 120° relative to the full RSC about a pivot point previously identified as a regulatory hub in Sth1, suggesting that large conformational changes are part of Sth1 regulation and RSC assembly. We also show that a conserved interaction between Sth1 and the nucleosome acidic patch enhances remodeling. As some cancer-associated mutations dysregulate rather than inactivate SWI/SNF remodelers, our insights into RSC complex regulation advance a mechanistic understanding of chromatin remodeling in disease states.
- 7 December 2020
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 28 (1) , 71-80
Structural insights into assembly and function of the RSC chromatin remodeling complex
SWI/SNF chromatin remodelers modify the position and spacing of nucleosomes and, in humans, are linked to cancer. To provide insights into the assembly and regulation of this protein family, we focused on a subcomplex of the Saccharomyces cerevisiae RSC comprising its ATPase (Sth1), the essential actin-related proteins (ARPs) Arp7 and Arp9 and the ARP-binding protein Rtt102. Cryo-EM and biochemical analyses of this subcomplex shows that ARP binding induces a helical conformation in the helicase-SANT–associated (HSA) domain of Sth1. Surprisingly, the ARP module is rotated 120° relative to the full RSC about a pivot point previously identified as a regulatory hub in Sth1, suggesting that large conformational changes are part of Sth1 regulation and RSC assembly. We also show that a conserved interaction between Sth1 and the nucleosome acidic patch enhances remodeling. As some cancer-associated mutations dysregulate rather than inactivate SWI/SNF remodelers, our insights into RSC complex regulation advance a mechanistic understanding of chromatin remodeling in disease states.
- Open Access
Sequential dynein effectors regulate axonal autophagosome motility in a maturation-dependent pathway
Autophagy is a degradative pathway required to maintain neuronal homeostasis. Neuronal autophagosomes form constitutively at the axon terminal and mature via lysosomal fusion during dynein-mediated transport to the soma. How the dynein-autophagosome interaction is regulated during maturation is unknown. Here, we identify a series of handoffs between dynein effectors as autophagosomes transit along the axons of primary neurons. In the distal axon, JIP1 initiates autophagosomal transport, while autophagosomes in the mid-axon require HAP1 and Huntingtin for motility. We demonstrate that HAP1 is a bonafide dynein activator, binding the dynein-dynactin complex via canonical and noncanonical interactions. JIP3 is found on most axonal autophagosomes but specifically regulates the transport of acidified autolysosomes. Inhibiting autophagosomal transport disrupts maturation, while inhibiting autophagosomal maturation perturbs the association and function of dynein effectors. Thus maturation and transport are tightly linked. These results describe a novel maturation-based dynein effector handoff on neuronal autophagosomes that is key to autophagosomal motility, cargo degradation, and the maintenance of axonal health. Summary Neuronal autophagosomes form in the distal axon and mature via fusion with lysosomes during their dynein-driven transport to the soma. Dynein is regulated on autophagosomes by distinct effector proteins—JIP1, HAP1, and JIP3—depending on location and autophagosomal maturity. In this sequential pathway, transport and maturation state are tightly linked to maintain neuronal health.
Open AccessSequential dynein effectors regulate axonal autophagosome motility in a maturation-dependent pathway
Autophagy is a degradative pathway required to maintain neuronal homeostasis. Neuronal autophagosomes form constitutively at the axon terminal and mature via lysosomal fusion during dynein-mediated transport to the soma. How the dynein-autophagosome interaction is regulated during maturation is unknown. Here, we identify a series of handoffs between dynein effectors as autophagosomes transit along the axons of primary neurons. In the distal axon, JIP1 initiates autophagosomal transport, while autophagosomes in the mid-axon require HAP1 and Huntingtin for motility. We demonstrate that HAP1 is a bonafide dynein activator, binding the dynein-dynactin complex via canonical and noncanonical interactions. JIP3 is found on most axonal autophagosomes but specifically regulates the transport of acidified autolysosomes. Inhibiting autophagosomal transport disrupts maturation, while inhibiting autophagosomal maturation perturbs the association and function of dynein effectors. Thus maturation and transport are tightly linked. These results describe a novel maturation-based dynein effector handoff on neuronal autophagosomes that is key to autophagosomal motility, cargo degradation, and the maintenance of axonal health. Summary Neuronal autophagosomes form in the distal axon and mature via fusion with lysosomes during their dynein-driven transport to the soma. Dynein is regulated on autophagosomes by distinct effector proteins—JIP1, HAP1, and JIP3—depending on location and autophagosomal maturity. In this sequential pathway, transport and maturation state are tightly linked to maintain neuronal health.